• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Patients With Coronavirus Disease 2019: A Retrospective Cross-sectio

tetano

Editor, Senior Moderator
J Med Virol


. 2020 May 26.
doi: 10.1002/jmv.26061. Online ahead of print.
Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Patients With Coronavirus Disease 2019: A Retrospective Cross-sectional Study


Xisheng Yan[SUP] 1 [/SUP], Fen Li[SUP] 2 [/SUP], Xiao Wang[SUP] 3 [/SUP], Jie Yan[SUP] 4 [/SUP], Fen Zhu[SUP] 1 [/SUP], Shifan Tang[SUP] 1 [/SUP], Yingzhong Deng[SUP] 1 [/SUP], Hua Wang[SUP] 1 [/SUP], Rui Chen[SUP] 1 [/SUP], Zhili Yu[SUP] 1 [/SUP], Yaping Li[SUP] 1 [/SUP], Jingzhou Shang[SUP] 1 [/SUP], Lingjun Zeng[SUP] 1 [/SUP], Jie Zhao[SUP] 1 [/SUP], Chaokun Guan[SUP] 1 [/SUP], Qiaomei Liu[SUP] 5 [/SUP], Haifeng Chen[SUP] 6 [/SUP], Wei Gong[SUP] 3 [/SUP], Xin Huang[SUP] 3 [/SUP], Yu-Jiao Zhang[SUP] 7 [/SUP], Jianguang Liu[SUP] 2 [/SUP], Xiaoyan Dong[SUP] 1 [/SUP], Wen Zheng[SUP] 3 [/SUP], Shaoping Nie[SUP] 3 [/SUP], Dongsheng Li[SUP] 1 [/SUP]



Affiliations

Abstract

Objective: This retrospective study was designed to explore whether neutrophil to lymphocyte ratio (NLR) is a prognostic factor in patients with coronavirus disease 2019 (covid-19).
Methods: A cohort of patients with covid-19 admitted to the Tongren Hospital of Wuhan University from January 11, 2020 to March 3, 2020 was retrospectively analyzed. Patients with hematologic malignancy were excluded. The NLR was calculated by dividing the neutrophil count by the lymphocyte count. NLR values were measured at the time of admission. The primary outcome was all-cause in-hospital mortality. A multivariate logistic analysis was performed.
Results: 1004 patients with covid-19 were included in this study. The mortality rate was 4.0% (40 cases). The median age of nonsurvivors (68 years) was significantly older than survivors (62 years). Male sex was more predominant in nonsurvival group (27; 67.5%) than in the survival group (466; 48.3%). NLR value of nonsurvival group (median 49.06, IQR 25.71-69.70) was higher than that of survival group (median 4.11, IQR 2.44-8.12, P < 0.001). In multivariate logistic regression analysis, after adjusting for confounding factors, NLR > 11.75 was significantly correlated with all-cause in-hospital mortality (OR = 44.351, 95% CI = 4.627-425.088).
Conclusions: These results suggest that the NLR at hospital admission is associated in-hospital mortality among patients with covid-19. Therefore, the NLR appears to be a significant prognostic biomarker of outcomes in critically ill patients with covid-19. However, further investigation is needed to validate this relationship with data collected prospectively. This article is protected by copyright. All rights reserved.

Keywords: Lymphopenia; Neutrophils; Pneumonia; Prognostic; SARS-CoV-2.
 
Back
Top Bottom